Pharmaceuticals

Global GLP-1 Receptor Agonist Market Overview: Trends Shaping Growth to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The GLP-1 Receptor Agonist Industry In 2025?

The GLP-1 receptor agonist market has experienced consistent expansion over recent years. This market is projected to expand from $13.58 billion in 2024 to $14.09 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.8%. Historically, this expansion has been driven by factors such as an increase in diabetes prevalence, proven clinical effectiveness, greater patient understanding and acceptance, worldwide health programs, and a growing patient preference for injectable treatments.

The GLP-1 receptor agonist market size is anticipated to experience robust expansion in the near future, reaching $17.36 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%. This projected growth throughout the forecast period is attributable to an increased emphasis on lifestyle management, the development of personalized medicine approaches, expanding therapeutic indications, the creation of next-generation products, and their integration into combination therapies. Significant trends for the forecast period include the introduction of oral formulations, a focus on combination therapies, strategic partnerships and collaborations, advancements in reimbursement policies and patient access, and the adoption of patient-centric approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9631&type=smp

What Are The Drivers Pushing New Developments In The GLP-1 Receptor Agonist Market?

The escalating occurrence of diabetes is projected to fuel the GLP-1 receptor agonist market in the coming period. Diabetes is a persistent illness stemming from the pancreas either producing insufficient insulin or the body’s inability to properly utilize its insulin, resulting in elevated blood sugar levels, a hallmark of this metabolic disorder. GLP-1 receptor agonists are employed in diabetes management to prompt the body to secrete more insulin, thereby assisting in lowering blood sugar levels, and thus, the growing prevalence of diabetes will stimulate market expansion. For instance, in March 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%, the highest value ever reported by the National Diabetes Audit (NDA). Consequently, the rising prevalence of diabetes is serving as a key driver for the GLP-1 receptor agonist market.

What Are The Major Segment Types Covered In The GLP-1 Receptor Agonist Market?

The glp-1 receptor agonist market covered in this report is segmented –

1) By Drug Class: Exenatide, Liraglutide, Dulaglutide, Lixisenatide, Other Drugs

2) By Route Of Administration: Parenteral, Oral

3) By End Users: Hospitals, Surgical Clinics, Other Users

Subsegments:

1) By Exenatide: Byetta, Bydureon

2) By Liraglutide: Victoza, Saxenda

3) By Dulaglutide: Trulicity

4) By Lixisenatide: Adlyxin

5) By Other Drugs: Semaglutide, Tirzepatide, Others

Which Trends Are Impacting The GLP-1 Receptor Agonist Market?

Product innovations are a prominent and expanding trend within the GLP-1 receptor agonist market. Major companies operating in the GLP-1 receptor agonist market are focused on developing innovative solutions to strengthen their position. For instance, in May 2022, Eli Lilly and Company, a US-based pharmaceutical company that creates medicines that make life better for people, launched the FDA-approved new Mounjaro, a GIP and GLP-1 receptor agonist. This product is specially designed using a single molecule that turns on the body’s receptors for the incretin hormones GIP and GLP-1. It is available as a pen auto-injector with a pre-attached, hidden needle that patients do not need to handle or see, and it comes in 6 doses.

Which Key Market Players Are Investing In Expansion And Innovation Of GLP-1 Receptor Agonist Market?

Major companies operating in the GLP-1 receptor agonist market include Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbH, Hanmi Pharm Co. Ltd., Pfizer Inc., Amgen Inc., Innovent Biologics Inc., Jiangsu Hengrui Medicine Co., Sun Pharmaceuticals Industries Ltd., PegBio Co. Ltd., Zealand Pharma A/S, Bristol-Myers Squibb Company, Chongqing Lummy Pharmaceutical Co. Ltd., Daiichi Sankyo Company Limited, Dong-A ST Co. Ltd., Eisai Co. Ltd., HanAll Biopharma Co. Ltd., Ipsen SA, Johnson & Johnson, Merck & Co. Inc., Novartis AG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/glp-1-receptor-agonist-global-market-report

What Are The Regional Market Dynamics Impacting The GLP-1 Receptor Agonist Industry?

North America was the largest region in the GLP-1 receptor agonist market in 2024. Asia-Pacific is expected to be the fastest-growing region in the GLP-1 receptor agonist market report during the forecast period. The regions covered in the GLP-1 receptor agonist market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The GLP-1 Receptor Agonist Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9631&type=smp

Browse Through More Reports Similar to the Global GLP-1 Receptor Agonist Market 2025, By The Business Research Company

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Group Typing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795